Introduction: new insights, treatments, and management strategies for ADPKD.
Cowley
Benjamin D
BD
Department of Nephrology/WP2250, University of Oklahoma Health Sciences Center, 920 Stanton L. Young Boulevard, Oklahoma City, OK 73104, USA. ben-cowley@ouhsc.edu
D065092:Antidiuretic Hormone Receptor Antagonists; D017209:Apoptosis; D001826:Body Fluids / Q000378:metabolism; D020169:Caspases / Q000378:metabolism; D049109:Cell Proliferation; D002986:Clinical Trials as Topic; D000242:Cyclic AMP / Q000378:metabolism; D006727:Hormone Antagonists / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D009398:Nephrology / Q000639:trends*; D016891:Polycystic Kidney, Autosomal Dominant / Q000378:metabolism / Q000473:pathology* / Q000628:therapy*; D017483:Receptors, Vasopressin / Q000378:metabolism; D020123:Sirolimus / Q000627:therapeutic use; D016896:Treatment Outcome
D065092:Antidiuretic Hormone Receptor Antagonists; D006727:Hormone Antagonists; D017483:Receptors, Vasopressin; D000242:Cyclic AMP; D020169:Caspases; D020123:Sirolimus